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Abstract.  Transport of the vesicular stomatitis virus- 
encoded glycoprotein (G protein) between the endo- 
plasmic reticulum (ER) and the cis Golgi compartment 
has been reconstituted in a cell-free system. Transfer is 
measured by the processing of the high mannose 
(mans_gGlcNAc2) ER form of G protein to the 
mansGlcNAc2  form by the cis Golgi enzyme a-man- 
nosidase I.  G protein is rapidly and efficiently trans- 
ported to the Golgi complex by a process resembling 
that observed in vivo. G protein is trimmed from the 
high mannose form to the mansGlcNAc2  form without 
the appearance of the intermediate man6_TGlcNAcz 
oligosaccharide species, as is observed in vivo. G pro- 
tein is found in a  sealed membrane-bound compart- 
ment before and after incubation.  Processing in vitro 
is sensitive to detergent, and the Golgi ~t-mannosidase 
I inhibitor  1-deoxymannorjirimycin.  Transport between 
the ER and Golgi complex in vitro requires the addi- 
tion of a high speed supematant (cytosol) of cell 
homogenates, and requires energy in the form of ATP. 
Efficient reconstitution of export of protein from the 
ER requires the preparation  of homogenates from mi- 
totic cell populations in which the nuclear envelope, 
ER, and Golgi compartments have been physiologi- 
cally disassembled before cell homogenization.  These 
results suggest that the high efficiency of transport 
observed here may require reassembly of functional 
organelles in vitro. 
A 
understanding  of the biochemical mechanisms  that 
control the vesicular transport of protein  between 
compartments of the secretory pathway of eucaryotic 
cells will require successful reconstitution  of individual  seg- 
ments of the pathway using novel cell-free systems. Transport 
of membrane glycoprotein between the cis and medial com- 
partments  of the Golgi complex has been successfully recon- 
stituted  in vitro (3,  13, 21, 22).  Studies in this  system are 
providing, for the first time, new insight into the biochemical 
mechanisms involved in intercompartmental  transfer  in this 
organelle (5, 49, 73, 74). Other stages in the exocytic pathway 
remain  to be reconstituted in vitro with high efficiency. An 
important  step in the delivery of protein to the cell surface 
is the selective export of proteins from their site of synthesis 
in the cellular endoplasmic reticulum  (ER).I The biochemi- 
cal basis for synthesis  (72), insertion  (75), and core-glyco- 
sylation (55) of protein in the rough endoplasmic  reticulum 
(RER) has been the subject of intense investigation.  In con- 
trast,  little  is known of the subsequent biochemical events 
that regulate export of protein from the ER to the next com- 
partment of the exocytic pathway, the Golgi complex. 
1. Abbreviations used in this paper:  CP, creatine phosphate; CPK, rabbit 
muscle  creatine  phosphokinase;  DMM,  1-deoxymannojirimycin;  ER, 
endoplasmic reticulum; NEM, N-ethylmaleimide; RER, rough endoplas- 
mic reticulum. 
Isolation  of yeast temperature-sensitive  mutants  that are 
pleiotropically  defective in export of both membrane-bound 
and secreted protein from the ER has established that a com- 
mon biochemical basis  regulates  trafficking  from this  or- 
ganelle (48). Comparative studies defining differences in the 
kinetics  of transport of a variety  of membrane-bound and 
secreted proteins (23, 40, 61, 65, 76),  the altered  secretion 
of genetically  engineered mutant  proteins (19, 24, 56, 57), 
and the requirement  for cofactors (53) or quaternary interac- 
tions (36, 37, 46, 50, 64) for export, suggest that signals en- 
coded in the primary sequence of a protein provide important 
information,  facilitating an initial step in interaction with this 
common transport machinery.  Transport  is vesicular;  pro- 
teins are delivered between compartments through the bud- 
ding and specific fusion of carrier vesicles (51). The enzymo- 
logical basis for these events in the exocytic pathway remains 
to be defined. 
To begin to understand  the first stage of transport,  export 
of newly  synthesized  protein  from the ER, we are using a 
model system based on the G protein of vesicular stomatitis 
virus (VSV).  The synthesis  (31, 41), posttranslational  pro- 
cessing (34, 35, 42, 66, 68), and transport of G protein from 
the ER to the cell surface (7, 8) has been extensively studied 
in vivo, and is indistinguishable  from normal cellular mem- 
brane-bound glycoproteins,  providing a sound experimental 
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tory pathway. During synthesis, G protein acquires two high 
mannose core-oligosaccharides (42).  Transfer of G protein 
from the ER to the cis  compartment of the Golgi in vivo 
results in the G protein oligosaccharides being trimmed from 
the mans_9GlcNAc2 forms to the mansGlcNAc2 species as a 
result of the early Golgi oligosaccharide-processing enzyme 
¢t-mannosidase I (1, 4, 34, 35, 67). Trimming of G protein 
can be followed directly in the mutant Chinese hamster ovary 
(CHO) cell line clone 15B, which is missing the medial Golgi 
processing enzyme N-acetylglucosamine transferase I  (16, 
26). As a consequence, further processing of the mansGlc- 
NAc2 oligosaccharide form to the complex structure by se- 
quentially acting ct-mannosidase II and glycosyltransferases 
in later compartments of the Golgi is blocked (15, 18, 34). 
G  protein is delivered to the cell surface in the mansGlc- 
NAc2 form, since processing, not transport, is the sole de- 
fect in clone 15B (62). 
Export of G protein from the ER in vivo can be readily 
distinguished from later transport steps between Golgi com- 
partrnents through use of the temperature-sensitive VSV mu- 
tant strain ts045,  in which G protein is found exclusively in 
the ER when ceils are incubated at the restrictive tempera- 
ture (39.5°C)  during infection (32, 33, 39, 44, 63, 77).  Shift 
of cells from the restrictive to the permissive temperature 
(32°C) in vivo results in the synchronous release of  G protein 
to the Golgi complex as shown both morphologically (7, 8) 
and biochemically through trimming to the mansGlcNAc2 
form (4). Transport of ts045 G protein between the ER and 
the Golgi apparatus in vivo has been shown to occur in two 
biochemically distinct steps: an early temperature-sensitive, 
ATP-dependent export (budding) step,  followed by a  tem- 
perature-  and ATP-insensitive step  providing for delivery 
(fusion) of G protein to the cis Golgi compartment contain- 
ing ¢t-mannosidase  I (1, 4). 
In this paper, using the transport of G protein as a model 
system, we provide evidence that we have successfully recon- 
stituted a new stage of  the exocytic  pathway in vitro, transport 
of protein from the ER to a cis Golgi compartment contain- 
ing a-mannosidase I. Transport is highly efficient and pro- 
ceeds with kinetics similar to those observed in vivo. Trans- 
port occurs between sealed membrane-bound compartments, 
requires energy in the form of ATP, and is dependent upon 
the addition of a cytosol fraction containing soluble compo- 
nents prepared from a high speed supernatant of centrifuged 
cell homogenates. 
Materials and Methods 
Materials 
A CHO cell line clone, 15B (26); a mouse cell line clone, 6 (25); VSV (Indi- 
ana serotype); and the mutant strain ts045 were obtained from J.  E. Roth- 
man,  Stanford  University,  Stanford,  CA.  L-[35S]methionine  (>800  Ci/ 
mmol)  was  purchased  from  Amersham Corp.,  Arlington  Heights,  IL. 
[3H]mannose (25  Ci/mmol) was purchased from New England Nuclear, 
Boston, MA.  1-deoxymannojirimycin (DMM) was purchased from Gen- 
zyme,  Boston,  MA;  swainsonine was purchased from  Calbiochem,  La 
Jolla, CA; rabbit muscle creatine phosphokinase and nocodazole were ob- 
tained from Sigma Chemical Co., St.  Louis, MO. 
Methods 
Growth and Synchronization of Cells. The CHO cell lines were grown in 
monolayer (10-cm dishes) in minimal essential medium (¢t-MEM) (Gibco, 
Grand Island, NY) supplemented with 10% fetal calf serum. The mouse L 
cell clone 6 was grown in DME supplemented with 15%  fetal calf serum 
and 0.11% sodium pyruvate. 
For preparation of synchronized mitotic cell populations of clone 15B the 
following protocol  was used. Confluent ceils (I  x  107 cells/10-cm LUX 
tissue culture dish [Miles Laboratories, Elkhart, IN]) were trypsin-released 
and seeded into new tissue culture dishes at a  cell density of 2.5  x  106 
cells/10-cm dish. Afar 24 h, the medium was replaced with fresh medium 
and the ceils were incubated for an additional 24 h. At this time, closely 
packed cells (2  x  107 cells/10-cm dish) were trypsin-released and seeded 
into new dishes at a cell density of 6.7  x  106 cells/10-cm dish in the pres- 
ence of 2.5 mM thymidine. After 14 h, cells were washed twice with 2 ml 
of TD buffer (138 mM NaCI,  5  mM KCI,  25  mM TRIS base, 0.4 mM 
Na2HPO4;  pH 7.4), and reincubated in the presence of 5 ml of 0t-MEM for 
5.5 h.  At 5.5 h  a  stock solution of nocodazole dissolved at 50 Ixg/ml in 
DMSO was added to each dish with mixing to a final concentration of 0.1 
I.tg/ml. After an additional 3-h incubation cells were harvested by the mitotic 
shake procedure (69). With this procedure, 50-70% of the total cell popula- 
tion in each dish was arrested in mitosis. The mitotic index of harvested cells 
ranged from 80 to 95%  for different preparations. The growth of cells to 
high density in the first step of the synchronization procedure is essential 
for the high yields of mitotic 15B cells. 
Infection ~fMitotic Cells with VSV. Protein synthesis is required just 
before entry of cells into mitosis (70).  Since virus infection rapidly inhibits 
host protein synthesis, the timing of virus infection is critical to insure a 
maximal yield of infected, mitotic cells. For infection of clone 15B with 
ts045, one-third of the total synchronized cells in each experiment were in- 
fected after a 5.5-h period of incubation in the absence of thymidine. Each 
dish was incubated with 10-20 plaque forming units of virus per cell in 1 ml 
of an infection medium containing a-MEM, 25 mM Hepes (pH 7.4), 0.1 
lag/ml nocodazole per 10-cm dish for 30 rain at 32°C with gentle rocking. 
Each  dish was  subsequently supplemented with  an additional  4  mi  of 
a-MEM containing 10% fetal calf serum and 0.1 lag/ml nocodazole, and in- 
cubated at 37°C for 2.0 h before harvest of ceUs by mitotic shake. With this 
procedure, 15-30% of the total cell population in each dish was arrested in 
mitosis. The mitotic index of harvested cells ranged from 60 to 80%  for 
different preparations.  A  mitotic cell population infected with wild-type 
VSV was obtained using an identical protocol, with the exception that all 
incubations were at 37°C. 
Infection oflnterphase  Cells. An asynchronous interphase cell popula- 
tion of either the 15B or clone 6 cell lines was infected with ts045 virus in 
a fashion identical to that described for mitotic cells, with the exception that 
nocodazole was not included in the infection media. After binding of virus 
to cells for 30 min at 320C, cells were incubated in the presence of a-MEM 
containing 10% fetal calf serum for 3.5-4.5 h at the restrictive temperature 
(39.5°C). Infection of cells with wild-type virus was carried out at 37°C. 
Labeling of Cells. Mitotic or interphase cell populations infected wth 
ts045 were washed three times with 5-ml portions of a  labeling medium 
(Joldik's minimal essential medium) containing nonessential amino acids 
(Gibco) and 20 mM Hepes-NaOH, pH 7.4, at 39.5°C. For labeling of mi- 
totic cells, the labeling medium contained, in addition, 0.1 Ixg/ml of nocoda- 
zole.  For experiments with [35S]methionine  the labeling medium lacked 
methionine. Cells were incubated for 5 min at 39.5°C (the restrictive tem- 
perature) before the addition of [35S]methionine  (25-50 ~tCi/ml). After a 
10-min pulse, unlabeled methionine was added to a final concentration of 
2.5 mM, and the incubation continued for 3 rain at 39.5°C before transfer 
of cells to a 10 ×  volume excess of ice-cold labeling medium to rapidly chill 
cells and inhibit transport. The infected, labeled mitotic cells were pooled 
with the uninfected mitotic cells harvested from the remaining two-thirds 
of the cells used in each experiment. 
For labeling of wild-type virus-infected cells, cells were washed in label- 
ing medium lacking methionine as described above, preincubated for 5 min 
at 37°C, and labeled for 3 min in the presence of [35S]methionine.  After a 
3-min pulse, unlabeled methionine was added to a final concentration of 2.5 
mM and cells immediately transferred to a  10x excess volume of ice-cold 
medium. Nocodazole was included additionally in the medium for labeling 
of infected mitotic cells. 
Preparation of Cell Homogenates. Cells in ice-cold labeling medium 
were pelleted for 3 min at 800 g, and washed once with a TEA buffer con- 
taining  10 mM triethanolamine and  150 mM KCI (pH  7.4).  Cells were 
pelleted and resuspended in a  H/KCI buffer containing 50  mM Hepes, 
90 mM KCI (pH 7.2) at a  ratio of 100-200 I11 pelleted cells per  1 ml of 
H/KC1  buffer,  and  homogenized  using  a  stainless  steel  ball-bearing 
homogenizer as described previously (2). A postchromosomal supernatant 
(PCS) was prepared where indicated by centrifugation of the homogenate 
for 5 min at 800 g. Cell homogenates (5-15 mg/ml protein with ,'~40%  of 
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homogenates prepared  from  ts045-infected interphase  15B cells 
(A), ts045-infected mitotic 15B cells (B), ts045-infected interphase 
15B cells incubated with nocodazole for 3.5 h before preparation 
of cell homogenates (C), and wild-type virus-infected mitotic 15B 
(D). G protein was labeled with [35S]methionine  at either the re- 
strictive temperature (ts045), or for 3 min at 37°C (wild-type; see 
Materials and Methods) to localize G  protein to the endoplasmic 
reticulum  before  cell  homogenization.  Homogenates  were  in- 
cubated on ice (0°C), 32°C (ts045), or 37°C (wild-type) for 60 rain 
as described in Materials and Methods. (E) Extent of trimming of 
G protein observed in vivo in ts045-infected 15B cells labeled at the 
restrictive  temperature  (39.5°C)  and  transferred  directly  to  ice 
(0 min),  or  incubated  at  the  permissive  temperature  (32°C)  for 
60 min.  For each incubation condition, transport was terminated 
and the extent of G  protein processing determined as described in 
Materials and  Methods. 
total protein being membrane protein) were used immediately for assay, or 
transferred in 125-1tl portions to 500-1xl microcentrifuge tubes and rapidly 
frozen in liquid nitrogen and stored at -80°C. For assay,  frozen fractions 
were thawed by a brief incubation at 37°C, and transferred to ice. Frozen, 
thawed fractions yielded results upon incubation in vitro identical to those 
obtained using fresh cell homogenates. Frozen crude cell homogenate is sta- 
ble for at least  1 mo under these conditions. 
To prepare a membrane fraction devoid of soluble cytosolic proteins, 125 
~tl of the cell homogenate was diluted into 5 ml of H/KCI buffer containing 
1 mM EDTA, and centrifuged in a rotor (SW 50.1; Beckman Instruments, 
Inc.,  Palo Alto,  CA)  for 20  min at  30,000  rpm.  The pellet was gently 
resuspended in 125 ~tl of H/KC1 buffer and used for incubation in vitro as 
indicated in Results. A cytosol fraction was prepared by centrifugation of 
cell homogenates in a SW 50.1 for 60 min at 49,000 rpm and the supernatant 
carefully removed to avoid disturbing the pellet. Where indicated the cytosol 
was depleted of low molecular components by gel filtration on a Sephadex 
G-25 column equilibrated with H/KCI buffer. Protein was determined by the 
method of Lowry (45). 
Incubation Conditions to Achieve Transport In  Vitro.  In addition to 
cell homogenate (10 to 50 I.tg per incubation), each assay contained in a total 
volume of 50  ltl  (final  concentrations):  50  mM  Hepes-KOH  (pH  7.2), 
90 mM KCI, 2.5  mM magnesium chloride,  1 mM ATP,  5  mM creatine 
phosphate  (CP),  and  0.2  IU  of rabbit  muscle  creatine  phosphokinase 
(CPK). The ATP-regenerating system was made fresh daily by mixing 20 
~tl CPK (2,000  IU/rnl, stored at  -80°C),  100 ~tl of 200 mM CP,  100 Ixl of 
40 mM ATP (Na form, neutralized with NaOH); and added as a concentrate 
to  the  assay  to  obtain  the  indicated  final  concentrations.  Additional 
modifications  of the standard incubation conditions are indicated in Results. 
Each assay was initiated by incubation for indicated time and temperature 
as described in Results.  Transport was terminated by transfer to ice, fol- 
lowed by the addition of 15 gl of a 5×  concentrate of a gel sample buffer 
(38) containing  12.5 ml of a  1 M "Iris (pH 6.8) buffer, 20 rnl glycerol,  0.5 g 
dithiothreitul (DTT), 4 g  SDS, 4 mg bromophenol blue, in a final volume 
of 40 ml H20. 
Quantitation of Transport.  Samples were processed for SDS gel elec- 
trophoresis using  10%  polyacrylamide gels (38),  treated  for autoradio- 
graphic enhancement by incubation for 30 min in 100 ml of  a 30% methanol 
solution containing 0.125 M salicylic acid (Na form; pH 7.0), dried, and au- 
toradiographed for 1-3 d (XAR-5 film, Kodak). The fraction of G protein 
processed to the mansGlcNAc2  form was determined by densitometry of 
the  exposed autoradiogram  using  a  transmission scanning densitometer 
(GS300; Hoefer Instruments, San Francisco, CA) connected to an IBM-XT 
with the GS350 integrating software (Hoefer Instruments). The quantitative 
relationship between appearance of the faster migrating band using SDS gel 
electrophoresis, and processing to the mansGlcNAc2  oligosaccharide form 
has been established previously (4). 
Oligosaccharide  Size Class Determination. Clone 15B mitotic cells in- 
fected with ts045  were labeled for 15 min at 39.5°C with [3H]mannose in 
labeling medium containing methionine, but with one-tenth the normal glu- 
cose level. A cell homogenate was prepared and incubated in vitro as de- 
scribed in Results.  Samples were processed for SDS  PAGE,  autoradio- 
graphed, and the G protein band excised by comparison of the dried gel to 
the exposed auloradiogram.  The excised gel was resuspended in a buffer 
containing 100 mM Tris-HCl (pH 8),  10 mM CaC12, 1 mM Na azide, 1.2 
mg/ml pronase, and digested for 36 h at 56°C with additional pronase (1.2 
mg/ml) added at 12 and 24 h of  incubation. The glycopeptides were digested 
with 0.02  U/ml of endoglycosidase H (Miles Laboratories Inc.) in 0.15 M 
citrate buffer, pH 5.5 for 24 h at 37°C. The released oligosaccharides were 
separated into component size classes by high resolution Biogel P-4 gel 
filtration chromatography using a  1  x  120-cm  column equilibrated with 
0.1 M  NaHCO3,  pH  8.0. Oligosaccharide  standards  were  generously 
provided by M. Snider, Carnegie Institute of Washington, Baltimore, MD. 
Results 
Preparation of  Active Crude Cell Homogenates 
Transport of G protein from the ER to the Golgi complex can 
be directly measured in vivo by the activity of the cis Golgi 
enzyme a-mannosidase I, which trims G protein oligosac- 
charides from the mans_9GlcNAc2 species to the mansGlc- 
NAc2 form (1,  4).  A  cell homogenate was prepared from 
a  VSV-infected  15B  interphase  cell  population  in  which 
[35S]methionine-labeled ts045  G  protein  was  localized to 
the ER by labeling at the restrictive temperature (39.5°C) be- 
fore homogenization. No trimming of G protein in vitro was 
observed with incubat,_'on  conditions that support inter-Golgi 
transport (Fig.  1 A) (3). These results raise the possibility 
that the transport function of one or both of these early com- 
partments was disrupted during cell homogenization. 
The ER is a single, reticular network of tubules and cister- 
nae  in  continuity  with  the  nuclear  envelope  and  found 
throughout the cytoplasm of the eukaryotic ceil. During cell 
homogenization the ER is sheared into microsomes. Micro- 
somes are reseaied ER vesicles, which,  in the case of the 
RER, contain bound ribosomes and retain the capacity for 
co-translational insertion and core-glycosylation of nascent 
protein in vitro (72).  The structure of the Golgi apparatus in 
vivo is controversial. While serial reconstructions in Sertoli 
cells support a  model in  which  it is  a  single,  continuous 
ribbon-like structure in which functionally distinct compart- 
ments are juxtaposed (52), the presence of several distinct 
Golgi stacks in other cell lines remains to be ruled out. The 
Golgi complex shears during homogenization to release sin- 
gle or stacked cisternal fragments similar to those observed 
in vivo (5, 6), which are active in inter-Golgi transfer reac- 
tions in vitro (3). 
One way to circumvent the problem of vesiculation during 
homogenization, which may disrupt the transport properties 
of these organelles for the ER to Golgi stage of the secretory 
pathway in vitro, is to obtain homogenates from cells under- 
going mitosis. In this stage of the cell cycle both the nuclear 
envelope (14) and the Golgi complex (54) are disassembled. 
The extent of disassembly of the ER is less well understood. 
Since the ER is an extension of the outer nuclear envelope, 
it seems  likely that the extensive reticular network of the 
nonnuclear rough and smooth ER membranes may be simi- 
larly disassembled  during mitosis.  Analysis  of serial  thin 
sections prepared from mitotic cells arrested at metaphase 
suggests that this is the case for CHO cells (Hermanowsky, 
A.,  and  W.  E.  Balch,  manuscript  in  preparation).  These 
physiologically  disassembled  structures  found  in  mitotic 
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Figure 2.  Oligosaccharide  size class  determination  of G protein 
trimming in vitro. Ts045-infected 15B mitotic cell homogenate la- 
beled  with  [3H]mannose (see  Materials  and  Methods)  was  in- 
cubated in vitro for 30 min on ice (solid circles), or for 30 min at 
32°C  (open circles). Samples were processed  for SDS gel elec- 
trophoresis,  G protein excised, and the oligosaccharides  prepared 
for chromatography on a Biogel P-4 column (1  ×  120 cm) as de- 
scribed in Materials and Methods. The arrows indicate the elution 
peaks of the oligosaccharide  standards. 
cells may be functionally stable to the homogenization condi- 
tions necessary to shear the plasma membrane to prepare a 
crude cell homogenate.  If so,  such intact mitotic compart- 
ments may provide the organelles in a form allowing recon- 
stitution of transport in vitro. 
To test the possibility that mitotic organelles may retain the 
functional capacity for export from the ER in vitro, a post- 
chromosomal supernatant (PCS) was prepared from mitotic 
clone 15B cells infected with the ts045 virus. G protein syn- 
thesized by ts045-infected mitotic cells during labeling with 
[35S]methionine  at  the  restrictive  temperature  (39.5°C)  is 
exclusively localized to the ER (4, 8, 20). When the PCS was 
incubated at 32°C for 60 min in the presence of ATP, a form 
of G  protein with increased electrophoretic mobility com- 
parable  to  that  observed  for  the  mansGlcNAc2  species 
formed in vivo was observed upon SDS gel electrophoresis 
of the incubated fraction (Fig.  1, B and E). 70% of the total 
G protein was processed to the form with the lower molecu- 
lar weight during  incubation  in vitro,  suggesting a  highly 
efficient process (Fig.  1 B). In these incubations, intact cells 
were not detected by light microscopy, eliminating the trivial 
explanation that the trimming observed in vitro was a G pro- 
tein transported in living ceils present in the incubation. No 
trimming in vitro was observed when an asynchronous inter- 
Figure 3. Kinetics of  processing of G protein in vitro. A 15B mitotic 
celt homogenate containing [35S]methionine-labeled ts045 G pro- 
tein was incubated in vitro for the indicated time at 32°C, processed 
for SDS gel electrophoresis,  and the amount of G protein trimmed 
to the mansGlcNAc2 form was quantitated as described in Materi- 
als and Methods. The autoradiogram (A) was used to quantitate the 
amount of G protein trimmed at each time point in vitro as shown 
in B (solid circles). A typical time course for processing of G pro- 
tein in vivo is shown (B, open circles) (4). 
phase 15B cell population was treated with nocodazole (an 
inhibitor of microtubule assembly) for 3 h before preparation 
of cell homogenates (Fig.  1 C).  These results suggest that 
preparation of active homogenates is  not  simply a  conse- 
quence  of  the  conditions  used  to  accumulate  cells  at 
metaphase (see Materials and Methods). However, trimming 
was  observed  in  vitro  when  homogenates  were  prepared 
from mitotic 15B cells infected with wild-type virus in which 
the  G  protein  was labeled  for 3  min with  [35S]methionine 
(Fig.  1 D). Under these conditions, the labeled G protein is 
localized to the ER before homogenization as a consequence 
of the short pulse (21, 22), and since all vesicular trafficking 
between ER and Golgi complex is inhibited in mitotic cells 
in vivo (20). 
These results tentatively suggest that we have successfully 
reconstituted in vitro transport between the ER and cis Golgi 
compartment. To provide additional evidence for this inter- 
pretation, the following lines of investigation were pursued. 
G Protein Is Processed to the Man~GlcNAc2 
Species In Vitro 
To demonstrate that the observed shift in molecular weight 
after incubation in vitro is the result of processing of G pro- 
tein oligosaccharides  to the  mansGlcNAcz form, as is ob- 
served in vivo, a PCS was prepared from ts045-infected mi- 
totic cells in which the core-oligosaccharides of G  protein 
had been labeled with [3H]mannose at the restrictive tem- 
perature.  These homogenates were incubated  at  32°C  for 
30 rain  in  vitro.  G  protein oligosaccharides were isolated 
and analyzed using high resolution Biogel P-4 chromatogra- 
phy. As shown in Fig.  2,  G  protein oligosaccharides were 
processed from the  high  mannose mans_gGlcNAc2  species 
to the mansGlcNAc2 form as  is observed in  vivo (4).  The 
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Figure 4. Trimming in vitro is sensitive to DMM. A 15B mitotic 
cell homogenate containing [3~S]methionine-labeled  ts045 G pro- 
tein was incubated in vitro for 60 min at 32°C as described in 
Materials and Methods in the presence of increasing concentrations 
of DMM as indicated. DMM was added immediately before initia- 
tion of transport. Samples were processed to determine the extent 
of G protein trimmed to the mansGlcNAc2 species as described in 
Materials and Methods. 
intermediate man7GlcNAc2  and man6GlcNAc2  forms of G 
protein  oligosaccharides  were  not  detected  at  this  time 
period of incubation in vitro. A similar result is observed in 
vivo (4). These results suggest that G protein is processed 
in vitro along the same enzymatic pathway observed in vivo. 
Kinetics of  G Protein Processing In Vitro 
The kinetics of G protein processing by a-mannosidase I to 
the mamGlcNAc2 species is shown in Fig. 3. Processing in 
vitro occurs with a reproducible 5-10 min lag period, fol- 
lowed by a linear phase of trimming, which approaches a pla- 
teau after 60-80 min of incubation (Fig.  3,  solid circles). 
These results closely resemble the kinetics of processing ob- 
served in vivo (Fig. 3, open circles) (4). 
The extent of processing of ts045 G protein and wild-type 
G protein in vitro at 32,  37, and 39.5°C were found to be 
similar after 90 min of incubation (data not shown). Since 
transport of G protein from the ER to the Golgi complex in 
vivo is inhibited by incubation of 15B cells at 39.5°C  (4), 
these results suggest that the temperature-sensitive pheno- 
type of G protein has not been reconstituted in vitro using 
the present homogenization and incubation conditions. 
Trimming Is Inhibited by Addition 
of  Deoxymannofirimycin 
DMM is a substrate analogue of  mannose and a noncompeti- 
tive inhibitor of the Golgi a-mannosidase ! (10), and ER-as- 
sociated ct-mannosidases that trim resident ER enzymes to 
the man7GlcNAc2  and mantGlcNAc2 species (12).  In con- 
trast, neither the ER ¢t-mannosidase that cleaves the mang- 
GIcNAc2  species  to  the  mansGlcNAc2  structure  (9),  the 
soluble form of the ER a-mannosidase released during cell 
homogenization (12), nor lysosomal mannosidases are sensi- 
tive to DMM (10, 12). Thus, DMM can be used to determine 
if the processing observed in vitro is a consequence of deliv- 
ery of G protein to the Golgi-associated trimming site con- 
taining  the  DMM-sensitive  a-mannosidase  I,  processing 
high  mannose  forms  to  the  mansGlcNAc2  species.  As 
shown in Fig.  4,  addition of increasing concentrations of 
DMM to the in vitro incubation immediately before initia- 
tion of transport resulted in a 50 % inhibition of trimming at 
a concentration of 60 gM.  50%  inhibition of trimming G 
protein in vivo in clone 15B cells is observed in the presence 
of  250 IxM DMM (data not shown), similar to concentrations 
required to inhibit processing in other cell lines (12). No in- 
hibition was observed by the incubation of homogenates in 
vitro in the presence of up to 1 mM swainsonine, a specific 
inhibitor of the medial Golgi compartment enzyme a-man- 
nosidase II (71) (data not shown), providing additional proof 
that the observed trimming is specific to the ct-mannosidase 
I activity present in the  15B cis Golgi compartment. 
Transport of  G Protein Occurs between 
Sealed Membrane-bound Compartments 
To determine ifG protein must reside in a sealed membrane- 
bound compartment for efficient trimming by a-mannosi- 
dase I  in vitro, crude homogenates were incubated in the 
presence of 0.1% Triton X-100 to solubilize membranes be- 
fore incubation. The solubilized form of a-mannosidase I is 
not inhibited by the addition of Triton X-100 under these con- 
ditions (67). As shown in Fig. 5 A, no processing of G pro- 
tein was observed after incubation for 60 min in the presence 
of detergent, suggesting that a solubilized form of G protein 
is not a substrate for trimming by a-mannosidase I under the 
conditions used to establish transport in vitro. This result 
further distinguishes the processing observed here from as- 
says developed to measure a-mannosidase I activity in cell 
fractions (10, 12,  15,  18). 
G protein is asymmetrically oriented in the ER membrane 
with a 29 amino acid carboxyl terminus extension on the 
cytoplasmic face of the ER (30). Before incubation in vitro, 
80 % of the total G protein in this preparation of cell homoge- 
nate was  protected from complete tryptic hydrolysis as  a 
consequence of its presence in a  sealed membrane-bound 
compartment (Fig.  5 B, lanes a,  b, and e).  The protected 
fragment of G protein, which includes the transmembrane 
and lumenal domains, is found as a truncated form with a 
higher electrophoretic mobility observed by SDS gel elec- 
trophoresis due to the cleavage of the cytoplasmically ex- 
posed, trypsin-sensitive carboxyl terminus (Fig. 5 B, lane b) 
(30). No G protein was detected when detergent was added 
before trypsin digestion (Fig. 5 B, lane e). When the cell ho- 
mogenate was incubated for 60 rain at 32°C, 60% of total G 
protein was processed to the trimmed form in vitro (Fig. 5 
B, lane c). After incubation, 65 % of the total G protein was 
found to be trypsin-resistant (Fig. 5 B, lane d). Of this total 
trypsin-resistant G  protein found after incubation in vitro 
(Fig.  5  B,  lane  d),  nearly  80%  was  found  to  be  in  the 
trimmed form (Fig. 5 B, lane d). These results suggest that 
for this homogenate preparation, the observed 60 % efficien- 
cy of transport of total G protein present in the incubation 
(Fig. 5 B, lane c) is an underestimate of the actual efficiency 
of transport of G protein present in sealed ER structures be- 
fore incubation.  Trypsin latency of G  protein present  in 
different preparations ranged from 50 to 85%,  suggesting 
that the ER is a fragile structure. 
These results indicate that the form of G protein found in 
sealed vesicles before incubation is  trimmed to the mans- 
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ment before and after incubation in vitro.  (A) A  15B mitotic cell 
homogenate  containing  [35S]methionine-labeled ts045 G  protein 
was incubated in vitro for 60 min at 32°C as described in Materials 
and Methods in the presence or absence of  TX-100 at a final concen- 
tration of 0.1%. (B) 15B cell homogenates containing [35S]methio- 
nine-labeled ts045 G protein were incubated in duplicate in vitro 
either on ice, or at 32°C for 60 min as described in Materials and 
Methods. The samples shown in lanes a and c were incubated for 
an additional 5 min at 32°C in the presence of a cocktail containing 
a mixture of  trypsin and soybean trypsin inhibitor at a final concen- 
tration of 100 and 200 ltg/ml, respectively. The samples shown in 
lanes b and d were incubated for an additional 5 rain at 32°C in the 
presence  of 100  ~tg/ml trypsin before the  addition of 200  gg/ml 
trypsin inhibitor. The sample shown in lane e was incubated with 
trypsin  as described  for lanes  b  and d  in the presence  of 0.1% 
TX-100 to solubilize the membranes.  The migration of the mang- 
GlcNAc2 and  mansGlcNAc2 oligosaccharide  forms  of the  trun- 
cated form of G protein missing the carboxyl terminus is indicated 
by the prefixes t-man9 and t-mans, respectively. 
GIcNAc2 form with high efficiency, and is found in a sealed 
membrane-bound compartment with the proper asymmetric 
membrane orientation after incubation in vitro. 
Role of  Cytosolic and Membrane-bound Components 
on G Protein Transport 
When the mitotic cell homogenate containing G protein was 
pelleted and washed to remove soluble cytoplasmic factors, 
trimming was not observed during incubation in vitro (Fig. 
6). When increasing concentrations of cytosol were added to 
the incubation containing washed membranes, both the ex- 
tent and efficiency of transport observed in the control (un- 
washed membranes) was recovered (Fig. 6). Mitotic cytosol 
can be quantitatively replaced with cytosol prepared from a 
nonsynchronized  (interphase)  cell  population,  indicating 
that the requirement for preparation of homogenates from 
mitotic cells is specific to the membrane fraction prepared 
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Figure 6.  Trimming  in vitro requires  a  soluble protein  fraction 
(cytosol) prepared  from cell homogenates. A 15B mitotic cell ho- 
mogenate containing [35S]methionine-labeled ts045 G protein was 
washed to remove soluble cytosolic proteins as described in Materi- 
als and  Methods,  and  25  Ixg of the membrane  fraction  was in- 
cubated in the presence of increasing concentrations of a high speed 
supernatant (cytosol) of a mitotic cell homogenate prepared as de- 
scribed in Materials and Methods. The time course of trimming in 
vitro for 60 Ixg of the unwashed cell homogenate is shown by the 
open circles. At each time point, transport was terminated by trans- 
fer to ice,  and samples processed  to determine  the extent of G 
processed to the mansGlcNAc2 form as described in Materials and 
Methods. 
from 15B cells (data not shown). Cytosol prepared from the 
mouse mutant L cell line clone 6, defective in processing of 
G  protein oligosaccharides beyond the mansGIcNAc2 form 
(25,  67), can quantitatively replace the cytosol requirement 
provided  by  the  mitotic  15B  cell  homogenate  (data  not 
shown).  In addition,  mitotic cytosol was not found to pro- 
mote transport of G protein between the ER and Golgi com- 
partments prepared from interphase cells (data not shown). 
No  transport was observed when  ts045  G  protein con- 
taining mitotic cell homogenate was treated for 10 min on ice 
with trypsin, followed by incubation in the presence of unin- 
fected, unlabeled  15B mitotic cell homogenate and trypsin 
inhibitor ('Ihble I). Inhibition was also observed when the 
ts045  G  protein-containing  homogenate was treated for 5 
min  on  ice  with  1  mM  N-ethylmaleimide (NEM)  before 
quenching of the unreacted NEM by addition of DTT and in- 
cubation in the presence of  uninfected, unlabeled 15B mitotic 
cell  homogenate  (Table  I).  These results  suggest that,  in 
addition  to  the  acceptor  Golgi  compartment  containing 
a-mannosidase I, component(s)  found on the donor com- 
partment membrane and in the cytosol are required for trans- 
fer in vitro. 
Appearance of the Trimmed Form of  G Protein 
Is ATP-dependent 
We have recently established that export of G  protein from 
the ER in vivo requires ATP (4). If the events observed here 
reflect those occurring in vivo, transport in vitro should be 
ATP-dependent.  When  extracts were incubated in  the  ab- 
sence of an ATP regenerating system, the extent of G protein 
processed was reduced by only  15 %  (Table I).  Since cell 
homogenates contain a  substantial pool (at least 1 mM) of 
ATP, extracts were depleted of endogenous ATP by the addi- 
tion of hexokinase and glucose. Under these conditions, pro- 
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Fraction  Addition or omission 
Fraction of total 
G trimmed at 
60 min of 
incubation 
at 32°C 
(A)  15B  Mitotic  None (complete)  0.65 
homogenate  +Trypsin  0.05 
+NEM  0.05 
(B)  15B  Mitotic  -ATP/CP/CPK  0.55 
homogenate  -ATP/CP/CPK,  +HK, +Glc  0.05 
+HK  0.55 
+Glc  0.60 
+EDTA  0.05 
(C) Washed  15B  -Cytosol  0.05 
mitotic  +Cytosol (+ADP)  0.15 
homogenate  +Cytosol, +ATP/CP/CPK  0.55 
(A) A 15B mitotic cell homogenate containing [35S]methionine-labeled ts045 G 
protein was washed as described in Materials and Methods. Resuspended mem- 
branes (50 I~g) were treated with 5 ~tg of trypsin for 10 min on ice before the 
addition of trypsin inhibitor (20 I~g), or were treated with NEM at a final con- 
centration of 1 mM for 5 min on ice before the addition of DTT at a final concen- 
tration of 2 mM. 25 ttg treated membranes were incubated in vitro in the pres- 
ence of 100 ~tg untreated,  uninfected mitotic  15B homogenate as described in 
Materials and Methods. Control incubations that contained equivalent concen- 
trations  of a premixture  of trypsin  and trypsin inhibitor,  or NEM and DTT, 
showed no inhibition of processing (data not shown). (B) 15B mitotic cell ho- 
mogenate containing ~SS]methionine-labeled ts045 G protein was incubated in 
the presence, or absence of an ATP-regenerating system (2.5 mM ATP, 5 mM 
CP, 0.2 IU of CPK) per 50 I~1 incubation cocktail. To remove endogenous ATP, 
hexokinase (HK; 1 IU/50121 incubation cocktail), and glucose (1 mM final) were 
added to the incubation cocktail where indicated. (C) Washed mitotic extracts 
were prepared and incubated with a cytosol fraction prepared by filtration over 
Sephadex G-25 to remove low molecular compounds as described in Materials 
and Methods. ADP was added to the incubation where indicated at a final con- 
centration of 2.5 raM. EDTA (Na form; pH 7.0) was added to the incubation 
where indicated at a final concentration  of 3 mM. 
cessing of G  protein to the mansGlcNAc2 form was com- 
pletely inhibited (Table I). A similar inhibition of transport 
was observed in the absence of ATP when membranes were 
washed and incubated in the presence of a cytosol fraction 
depleted of ATP by Sephadex G-25 gel filtration (Table I). 
Processing of G protein in the presence of ATP was inhibited 
by the addition of EDTA to the assay (Table I). 
Figure 7. Interphase donor ER is active in vitro in the presence 
of mitotic homogenates. 15B (lanes a and b) or clone 6 (lanes c-h) 
interphase cell homogenates (15 ~tg) containing [35S]methionine- 
labeled ts045 G protein were incubated alone (lanes c and d), in 
the presence of 55 ~tg protein of 15B mitotic cell homogenate (lanes 
a, b, e, and f), or in the presence of 55 lxg 15B interphase cell ho- 
mogenate (lanes g and h), as described in Materials and Methods, 
on ice (0 min), or at 32°C for 60 min. Samples were processed for 
SDS gel electrophoresis to separate the untrimmed and trimmed 
forms of G protein as described in Materials and Methods. 
Interphase Donor Homogenates are Active In Vitro in 
the Presence of  Mitotic Homogenates 
Several interpretations could account for the efficient  activity 
of mitotic cell homogenates for export of G protein from the 
ER. The first possibility is that the mitotic homogenates pro- 
vide either an active donor ER,  an active acceptor Golgi 
compartment, or are essential for preparation of both com- 
partments. A second possibility is that during incubation of 
the mitotic cell homogenate in  vitro,  physiologically dis- 
assembled  organdies  are  reassembled to  form functional 
compartments.  This  interpretation is  based  on the  recent 
evidence that the nuclear envelope (and possibly other or- 
ganelles) present in homogenates prepared from CHO cells 
are reassembled in vitro using similar incubation conditions 
(14). 
To test for these various possibilities, a donor ER mem- 
brane containing homogenate was prepared from an asyn- 
chronous  interphase  15B  cell  population  that  contained 
[35S]methionine-labeled G protein in the ER. As shown pre- 
viously, G  protein is  not processed when  interphase cell 
homogenates are incubated in vitro (see Fig. 1 A). If the do- 
nor ER homogenate containing  G  protein prepared  from 
interphase cells is incubated with a mitotic 15B cell homog- 
enate containing the acceptor Golgi compartment and trim- 
ming of G protein is not observed, then it must be concluded 
that the interphase donor ER is a labile compartment that has 
to be provided by the mitotic cell homogenate. On the other 
hand,  if trimming  is  observed, then mitotic homogenates 
provide either an active Golgi acceptor compartment, or ac- 
tivate transport of G from the interphase donor ER compart- 
ment in some other fashion. As shown in Fig. 7 (lane b), in- 
cubation of an interphase donor ER homogenate containing 
G protein with the mitotic cell homogenate resulted in 50 % 
of the total G protein being processed to the trimmed form. 
To provide additional evidence that export of  G protein can 
occur from an ER compartment prepared from interphase 
cells, a donor fraction was prepared from the mouse L cell 
line clone 6 (25). In the infected clone 6 cell line, G protein 
is transported to the cell surface with oligosaccharides in the 
high  mannose  (mansGlcNAc2)  form  (42),  indicating  that 
processing of G protein, not transport, is the only apparent 
defect in this mutant (25, 42). For trimming to occur in vitro, 
G protein must be transferred from the ER membranes found 
in the homogenate of the clone 6  cell line to the acceptor 
Golgi compartment containing a-mannosidase I provided by 
the separate addition of the 15B cell homogenate to the incu- 
bation (see Fig. 10). When homogenates were prepared from 
interphase clone 6 cells in which ts045 G protein was labeled 
at the restrictive temperature with [35S]methionine,  no trirn- 
ming was observed during incubation in vitro in the presence 
of uninfected interphase 15B cell homogenates (Fig. 7, lane 
h). In contrast, 60% of the G protein oligosaccharides were 
trimmed in vitro by incubation in the presence of a homoge- 
nate prepared from the uninfected mitotic 15B cell line (Fig. 
7, lane f). The extent of G protein oligosaccharide process- 
ing was found to be proportional to the concentration of the 
mitotic 15B membranes present in the assay (Fig. 8). These 
results emphasize the importance of interorganelle transfer 
of G protein in vitro, and support the interpretation that the 
efficiency previously observed during transport of G protein 
present in the ER of mitotic cell homogenates (Fig.  1 B) is 
not simply a consequence of  a labile donor ER compartment. 
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Figure 8. Dependence of processing in vitro on the acceptor Golgi 
compartment containing a-mannosidase  I. Clone 6 interphase cell 
homogenates  (20  gg protein)  containing  [sSS]methionine-labeled 
ts045 G protein were incubated in vitro in the presence of increasing 
concentrations of a washed 15B mitotic homogenate, and 60 pg of 
15B mitotic cytosol (see Materials and Methods). Samples were in- 
cubated for 60 min at 32°C, processed for SDS gel electrophoresis, 
and the fraction of the total G protein in the trimmed form was de- 
termined as described  in Materials and Methods. 
When wild-type G protein was labeled with [3SS]methio- 
nine in infected interphase clone 6 cells for 3 min and chased 
in vivo at 37°C before preparation of cell homogenates, trim- 
ming in vitro was lost with a half-time of •12  min (Fig. 9). 
Under  these  conditions,  G  protein  oligosaccharides  are 
found in the mansGlcNAc2 form during transport to the cell 
surface in vivo and are thus a possible substrate for a-man- 
nosidase I at each stage of the secretory pathway (see Fig. 
10). We can conclude from these results that G protein only 
transiently occupies an early donor ER compartment in vivo, 
which is active in vitro for transport to the cis Golgi compart- 
ment containing a-mannosidase I. These results rule out the 
possibility that nonspecific fusion between membrane struc- 
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Figure 9. G protein only transiently occupies a compartment during 
transport to the cell surface in vivo that is active in vitro. Wild-type 
virus-infected  clone 6 interphase cells were labeled with PS]me- 
thionine for 3 min at 37°C before chase in the presence of excess 
unlabeled methionine. At each time point a cell homogenate was 
prepared and 25 pg was incubated in vitro in the presence of a cell 
homogenate prepared from uninfected mitotic 15B cells (75 I~g)  for 
60 min at 37°C as described in Materials and Methods.  Samples 
were processed,  and the fraction of the total G protein trimmed to 
the mansGlcNAc2 form in vitro for each time point of chase in 
vivo was determined  as described  in Materials and Methods. 
tures containing G protein and the cis Golgi compartment is 
responsible for the observed trimming, and clearly illustrates 
the high specificity of the reconstituted transport step. 
Discussion 
Trimming Measures Transport of G Protein 
between the ER and a cis Golgi Compartment 
The reconstitution of transport of protein through the secre- 
tory pathway in vitro poses a major challenge in developing 
novel assays that faithfully measure the steps occurring in 
vivo. A number of criteria are important to establish the va- 
lidity of the events observed in vitro to those occurring in 
vivo. It is necessary to define the cellular localization of the 
transported protein before incubation (donor compartment), 
and the processing activity marking the acceptor compart- 
ment.  These data identify the segment of the total cellular 
pathway being studied in vitro. A second consideration is to 
demonstrate that the events occurring in vitro are a conse- 
quence of transfer between sealed membrane-bound com- 
partments.  In addition,  authentic transport in vitro should 
occur  using  physiological  conditions  with  the  efficiency, 
specificity, and kinetics approaching those observed in vivo, 
and measure a vectorial process that is dependent upon both 
donor  and  acceptor membranes.  Using  these  criteria,  we 
have provided evidence that a new segment of the secretory 
pathway has been reconstituted in vitro, transport of protein 
between the ER an the cis Golgi compartment. 
To ensure that the events measured here were not a mea- 
sure of inter-Golgi transport (3,  21,  22),  the mutant virus 
ts045 was used to prepare extracts in which G protein was 
localized to the ER in the high mannose (mans-gGlcNAc2) 
form before preparation of cell homogenates (4). The accep- 
tor  compartment  was  chosen  to  reflect  an  early  Golgi- 
associated processing  step conferred by a-mannosidase I. 
a-Mannosidase  I  has  been  purified  from Golgi  fractions 
(67). Trimming of G protein to the mansGlcNAc2 species is 
the activity characteristic of the Golgi-associated tt-manno- 
sidase I and not the ER-associated mannosidases that trim 
resident ER proteins  to,  but not further than,  the mans~- 
GlcNAc2  species  (11, 28,  29,  43,  58).  This  result  is  sup- 
ported by kinetic studies in which trimming in vivo to the 
mansGlcNAc2 form (4) is coincident with the morphologi- 
cal data showing transfer of G protein to the Golgi complex 
in vivo (7, 8). The Golgi stack is a polarized organdie con- 
sisting of cis, medial,  and trans compartments (17). While 
the  morphological localization  of a-mannosidase  I  in the 
Golgi stack remains to be established with immunoelectron 
microscopy, we recently provided functional evidence that 
et-mannosidase I occupies a cis Golgi compartment (1) pre- 
ceding the medial Golgi compartment containing N-acetyl- 
glucosamine transferase I (16). Thus, transport in this assay 
measures a stage preceding inter-Golgi transfer in vitro (22). 
Since both ts045 G protein and wild-type G protein are trans- 
ported from the ER with similar efficiency in vitro, the trans- 
port events observed here are not simply a measure of trans- 
fer of ts045 G protein from a unique temperature-sensitive 
site in the ER. 
The following lines of evidence suggest that transport of 
G protein in vitro occurs along the same compartmentalized 
pathway observed in vivo. (a) Addition of detergent to solu- 
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Figure  10. Working model for transport of G protein between the 
ER and the Golgi complex in vitro. The donor ER compartment 
is prepared from the clone 6 mutant cell line defective in the pro- 
cessing of G protein past the mansGlcNAc2 form in vivo. The do- 
nor ER is incubated in vitro in the presence of an acceptor Golgi 
compartment containing a-mannosidase I prepared from the 15B 
cell line. Trimming of G protein in vitro to the mansGlcNAc2 spe- 
cies occurs only when G protein is transported between the two dis- 
tinct compartments in the presence of cytosol and ATP. 
bilize membranes before incubation inhibited trimming of 
G  protein to the mansGlcNAc2 species.  (b) Incubation of 
donor membranes with trypsin before and after incubation 
indicated that G protein is predominately found in a sealed 
vesicle with the proper asymmetric membrane orientation. 
(c) Transport in vitro reflected the efficiency and kinetics ob- 
served in vivo. In homogenates that were devoid of intact 
cells, up to 80 % of the G protein that was found in a sealed 
membrane-bound compartment before incubation was pro- 
cessed to the mansGlcNAc2 species after 60 min of incuba- 
tion. This result is in contrast to a recent report in which an 
in vitro assay for transport of invertase from the ER to the 
Golgi complex using interphase yeast cell homogenates was 
proposed (27). Efficiency of transport to the Golgi complex 
was found to be 2-5 % of the total invertase present in the ER 
before incubation in vitro. This low level of transport could 
not be reliably detected during incubation of 15B interphase 
homogenates with the present assay.  (d) Transport in vitro 
requires energy in the form of  ATP, as is required in vivo (4). 
(e) Transport requires factors present in the soluble fraction 
(cytosol) of crude cell homogenates. Soluble cytosolic com- 
ponents are also essential for inter-Golgi transport in vitro 
(3, 21). 
We have not been able to reproducibly reconstitute in vitro 
the temperature-sensitive phenotype of  ts045 export from the 
ER observed in vivo. Whether this reflects a problem related 
to homogenization of cells at the permissive temperature (on 
ice), or is indicative that at least some aspects of the initial 
temperature-sensitive step observed during export in vivo 
are not faithfully reconstituted in vitro, remains to be deter- 
mined. With the recent report of the differences in the oligo- 
meric structure of ts045  G  protein at the permissive and 
restrictive temperatures in vivo (36), we can test these possi- 
bilities directly. 
Specificity of trimming was assessed by several different 
criteria. The requirement for G  protein in a  sealed mem- 
brane  compartment  before  and  after  incubation  argues 
against the interpretation that a soluble form of a-mannosi- 
dase I is responsible for the trimming observed in vitro. This 
result is consistent with the observation that cytosol prepared 
from homogenates of the clone 6 cell line defective in pro- 
cessing of G protein past the mansGlcNAc2 oligosaccharide 
form in vivo supports trimming in vitro (25, 67). G protein 
oligosaccharides were  shown to  be  directly processed in 
vitro  to  the  a-mannosidase  I  product,  the  mansGlcNAc2 
oligosaccharide form. The intermediate mantGlcNAc2 and 
manTGlcNAc2  structures,  products  characteristic  of trim- 
ming by ER-associated a-mannosidases in vivo (12, 43, 58), 
were not observed. Ts045 G protein is slowly processed to 
these intermediate structures in vivo by prolonged incuba- 
tion (60 min) of cells at the restrictive temperature (4, 29), 
or during incubation of mitotic cells at the permissive tem- 
perature in the presence of nocodazole (20). These results 
suggest that oligosaccharides present on G protein are poten- 
tial substrates for these ER-associated a-mannosidases that 
trim resident ER proteins to the  mantGlcNAc2  form, but 
that G  is  likely to be exported rapidly to the Golgi stack 
where it is principally processed by a-mannosidase I. Incu- 
bation in the presence of the inhibitors DMM  and swain- 
sonine provided direct evidence that processing to the mans- 
GlcNAc2 form in vitro by the acceptor Golgi compartment 
is a result of the DMM-sensitive a-mannosidase I. 
A second line of evidence for specificity was provided by 
preparation of the donor ER compartment from the clone 6 
cell line. As shown in the model presented in Fig. 10, G pro- 
tein present in the donor clone 6 ER was trimmed in vitro 
only when provided with a 15B acceptor Golgi compartment 
containing  a-mannosidase  I.  This  result  eliminates  the 
trivial explanation that the processing observed here reflects 
an anomalous mixing (fusion) of ER and Golgi membranes 
during homogenization of  cells, and provides direct evidence 
for transfer between distinct donor ER and acceptor Golgi 
compartments in vitro. A rapid loss of G protein from a do- 
nor compartment that is active in vitro was observed during 
transport to the cell surface in vivo in the clone 6 cell line. 
While it is not possible to determine biochemically the rate 
of G protein transport from the ER to the Golgi complex in 
the clone 6 cell line (since the first Golgi-associated process- 
ing step is defective), we have found that the transport time 
of G protein to the cell surface in clone 6 is similar to that 
observed in the clone 15B cell line (Balch, W.  E., unpub- 
lished results). Since loss of donor activity in vitro was simi- 
lar to the half-time observed for export of G protein from the 
ER in the 15B cell line (4), these data support the conclusion 
that the principal donor in vitro is the ER. A transient donor 
population is also observed for inter-Golgi transfer in vitro 
(22, 59, 60). However, in this assay, G protein must be trans- 
ported to the cis Golgi compartment before activity is ob- 
served in vitro. Both the transient nature of the ER donor 
compartment containing G protein, and the high efficiency 
of  trimming observed in vitro argue against a model in which 
nonspecific fusion between compartments is responsible for 
the events observed here. 
Cytoplasmically oriented components present on the do- 
nor compartment are required for transport in vitro. This 
was demonstrated by loss of activity after trypsin digestion, 
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(NEM).  Compartments  active in  inter-Golgi transport  in 
vitro are similarly trypsin- and NEM-sensitive (2, 5). Tryp- 
sin lability of the donor compartment may reflect a require- 
ment  for additional  ER  membrane components.  Alterna- 
tively, since the proteolysis conditions used here cleave the 
carboxyl terminus of G protein, these results may reflect a 
requirement for the cytoplasmic domain of G protein as is 
observed in vivo (30). G protein expressed from the cloned 
cDNA of the membrane-anchored construction missing the 
cytoplasmic carboxyl terminus domain is blocked in export 
from the ER (57). Characterization of the transport in vitro 
of the various truncated forms of G protein present in the ER 
of  homogenates prepared from cells transfected with deletion 
mutants of the cloned cDNA of G protein (24, 56, 57) should 
provide evidence to address these possible requirements for 
export. 
In the present analysis we cannot unequivocally rule out 
the interpretation that the ct-mannosidase I present in the 15B 
Golgi cisternae is delivered to the ER in vitro in a fashion 
counter to the normal vectorial flow of protein in vivo. In this 
interpretation, the Golgi compartments containing a-man- 
nosidase I could putatively fuse with the ER compartment 
containing G protein, resulting in trimming of the ER-asso- 
ciated G protein molecules. A prediction from this interpre- 
tation is that incubation of the clone 6 donor ER with mitotic 
acceptor Golgi prepared from wild-type CHO cells that con- 
tain additional Golgi-associated processing enzymes would 
result in processing of G protein to the complex oligosaccha- 
rides  forms  containing  additional  N-acetylglucosamine, 
galactose, and sialic acid. This result is not observed. G pro- 
tein is trimmed to the mansGlcNAc2 form, as is observed in 
the presence of an acceptor Golgi prepared from the 15B cell 
line (Beckers, C.,  and W.  E.  Balch, unpublished results), 
emphasizing the point that the present assay conditions pro- 
mote efficient transfer only between the ER and the cis Golgi 
compartment. While the kinetics, efficiency, and high speci- 
ficity of the processing events observed here support a model 
in which transport between ER and Golgi stack has been 
reconstituted, direct evidence for transfer of G protein to the 
Golgi cisternae will require application of immunoelectron 
microscopy, a line of investigation we are currently pursuing. 
The Role of Mitotic Homogenates for Transport In Vitro 
Based on the observation that the Golgi apparatus and nu- 
clear envelope are disassembled  during  mitosis,  we have 
used electron microscopy and serial thin sections of mitotic 
cells to determine that the nonnuclear RER is similarly dis- 
assembled (Hermanowsky, A., and W. E. Balch, manuscript 
in preparation). It was proposed that such physiological dis- 
assembly would provide organelles more amenable to cell 
breakage protocols than the intact structures found in inter- 
phase cell populations. The appearance of the trimmed form 
of G protein during co-incubation of an interphase donor ER 
and a mitotic acceptor Golgi compartment ruled out the sim- 
ple interpretation that mitotic homogenates are only impor- 
tant for preparation of a functional donor ER compartment. 
The data presently support two other models regarding the 
role of mitotic membranes in transport in vitro. 
In the first interpretation of the role of mitotic membranes 
in the assay, the acceptor Golgi compartment is the homog- 
enization-sensitive component.  This is because G  protein 
present  in  an  interphase  clone  6  ER  compartment  was 
efficiently processed in vitro when incubated with a mitotic 
15B cell homogenate. The converse experiment, incubation 
of G protein present in mitotic clone 6 donor ER with an ac- 
ceptor Golgi compartment provided by an asynchronous in- 
terphase 15B homogenate, has not been possible due to our 
inability to prepare infected, mitotic clone 6 cell populations. 
The reason(s) behind the apparent ability of the interphase 
cis  Golgi compartment to  function efficiently as  a  donor 
during inter-Golgi transfer in vitro (3,  21,  22),  but not as 
an acceptor for export from the ER in vitro may reflect either 
inactivation of the compartmentalized trimming activity of 
a-mannosidase I per se, or differential sensitivity to homog- 
enization of Golgi cisternae function in these two stages  of 
the secretory pathway. 
A second interpretation consistent with our results is that 
the mitotic homogenate promotes reassembly or repair of or- 
ganelles in vitro. It has recently been established that in addi- 
tion to organelle disassembly, all vesicular trafficking is ar- 
rested in mitotic cells (20). G protein accumulates in the ER 
in the mans_9GlcNAc2 oligosaccharide forms in mitotic cells 
arrested at metaphase with nocodazole (20). Three lines of 
evidence support the interpretation that factors required for 
maintenance of the mitotic state are inactivated during cell 
homogenization. In addition to appearance of the trimmed 
form of G protein in vitro reflecting reinitiation of transport, 
interphase cytosol was found to substitute for mitotic cytosol, 
and we have observed that both the nuclear envelope and the 
RER are reassembled during incubation of the donor and ac- 
ceptor crude homogenates in vitro (Hermanowsky, A., and 
W. E. Balch, unpublished observations). The appearance of 
reassembled nuclei in vitro from CHO homogenates using 
similar  incubation  conditions  has  been  well  documented 
(14).  In  addition,  nuclei  reassembled  in  vitro  have been 
shown to be a useful model system for studying import of 
protein into the nucleus in a cell-free system (47), attesting 
to  the  remarkable  facility  of  reassembled  organelles  to 
authentically reconstitute functions observed in vivo. If the 
efficiency  of G protein export observed here is a consequence 
of reassembly of donor ER and Golgi acceptor membranes 
into functional organelles, then the apparent donor activity of 
interphase ER membranes containing G protein may be a re- 
sult of their incorporation into the reassembling mitotic ER. 
Both interpretations of the role of mitotic homogenates in 
the transport of G protein in vitro support a model in which 
we are measuring a specific transport event between the ER 
and a cis Golgi compartment. Through selective enrichment 
of intermediate steps in transfer in vitro, and fractionation of 
the required components, a number of new approaches can 
now be used to understand the biochemical machinery re- 
quired for both the export and delivery steps. In addition, the 
choice of G protein as a model system for ER export provides 
the potential for contrasting the requirements for this early 
stage  to  the  requirements  for inter-Golgi transfer  (5,  49, 
73, 74). 
Providing an enzymological definition to the mechanisms 
that regulate transport from the ER should provide insight 
into the biochemical rules for organization of the secretory 
pathway in the living cell. 
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